Mevinor vs Ultrasonyx: Revenue, Funding & Team Size Compared
Last updated
Mevinor generates $220K in revenue; Ultrasonyx generates $178.9K. Mevinor is 1.2× bigger than Ultrasonyx by revenue. The table below compares Mevinor and Ultrasonyx on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  MevinorThis company |  Ultrasonyx |
|---|---|---|
| Revenue | $220K | $178.9K |
| Team size | 2 | 2 |
| Founded | Not disclosed | 2016 |
| HQ | United States | Princeton, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Mevinor at a glance
Mevinor generates $220K in revenue with 2 employees, headquartered in United States.
- Revenue
- $220K
- Team size
- 2
Mevinor is developed using Salesforce technology which is our PRM cloud tool. Mevinor is the first tool in India using salesforce in healthcare. It’s a packaged application comes with saleforece platform. Mevinor is the best PATIENT…
Ultrasonyx at a glance
Ultrasonyx generates $178.9K in revenue with 2 employees, headquartered in Princeton, United States.
- Revenue
- $178.9K
- Team size
- 2
- Founded
- 2016
Provider of next-generation medical imaging techniques intended to provide accurate diagnosis and treatment. The company's services are cloud based leveraging group data in the cloud server to optimize the image quality, achieves a higher…
Other Mevinor alternatives
Mevinor competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Mevinor vs Ultrasonyx: frequently asked questions
Is Mevinor or Ultrasonyx bigger?
Mevinor is the bigger company by revenue, at $220K against $178.9K for Ultrasonyx.
How much revenue does Mevinor make?
Mevinor generates $220K in annual revenue with a team of 2.
How much revenue does Ultrasonyx make?
Ultrasonyx generates $178.9K in annual revenue with a team of 2.